Vimarsana
Biggest News Aggregation in the World

Marco Krieger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marco Krieger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marco Krieger Today - Breaking & Trending Today

Diplomatic rift with China results in shortage of active ingredient to produce vaccines in Brazil - Vimarsana News

Diplomatic rift with China results in shortage of active ingredient to produce vaccines in Brazil

All it takes for China to resume shipping IFA is an apology from Bolsonaro São Paulo Governor Joao Doria Friday blamed Brazilian President Jair Bolsonaro for a diplomatic crisis with China, which led to the suspension of supplies to manufacturing vaccines against the coronavirus. The Butantan Institute, which depends from the state of São Paulo, Friday stopped manufacturing the Coronavac immunizer due to the lack of Active Pharmacological Input (IFA), it was announced. Doria said that there was “a diplomatic friction caused by disastrous statements by the federal govern...

Brazil eyes July for full local production of AstraZeneca vaccine - Vimarsana News

Brazil eyes July for full local production of AstraZeneca vaccine

3 Min Read RIO DE JANEIRO (Reuters) - Brazil could begin full production of AstraZeneca Plc’s COVID-19 vaccine by July if regulators allow, an official at biomedical center Fiocruz said, moving up by 100 days the timeline to produce shots without imported ingredients. FILE PHOTO: A healthcare worker holds a vial of the AstraZeneca/Oxford coronavirus disease (COVID-19) vaccine at a public hospital in Rio de Janeiro, Brazil, January 27, 2021. REUTERS/Pilar Olivares Fiocruz Vice President Marco Krieger told Reuters that, if health regulator Anvisa waives some controls, the biomedical institute...

Brazil eyes July for full local production of AstraZeneca vaccine - Vimarsana News

Brazil eyes July for full local production of AstraZeneca vaccine

Brazil eyes July for full local production of AstraZeneca vaccine Reuters 3/15/2021 By Rodrigo Viga RIO DE JANEIRO (Reuters) - Brazil could begin full production of AstraZeneca Plc's COVID-19 vaccine by July if regulators allow, an official at biomedical center Fiocruz said, moving up by 100 days the timeline to produce shots without imported ingredients. Fiocruz Vice President Marco Krieger told Reuters that, if health regulator Anvisa waives some controls, the biomedical institute could move up the Sept. 30 target date for 100% local production of the shot by AstraZeneca and Oxford Univ...

Source: msn.com
Brazil's Fiocruz delays AstraZeneca vaccine registration as it awaits fast-track approval - Vimarsana News

Brazil's Fiocruz delays AstraZeneca vaccine registration as it awaits fast-track approval

By Reuters Staff 1 Min Read RIO DE JANEIRO, Jan 14 (Reuters) - Brazilian biomedical center Fiocruz has put back filing its request to register the COVID-19 vaccine developed by AstraZeneca PLC until next week, its vice president Marco Krieger said. Fiocruz had originally planned to file the request on Friday, but Krieger said it was best to wait for the emergency authorization request it expects health regulator Anvisa to grant on Sunday. Reporting by Pedro Fonseca Editing by Chris Reese

Brazil's Fiocruz to Seek Regulatory Approval for Oxford/AstraZeneca Vaccine - Vimarsana News

Brazil's Fiocruz to Seek Regulatory Approval for Oxford/AstraZeneca Vaccine

Brazil to Get 100 Million Vaccine Doses in First Half of 2021 The federal government of Brazil expects to receive 100 million doses during the first half of 2021 as part of their AstraZeneca order. Marco Krieger, vice president of health production and innovation at Fiocruz institute also confirmed that January 15 milestone with Reuters. AstraZeneca was first seen as a frontrunner in the development of the COVID-19 vaccine. But it has since been overtaken by drugmaker Pfizer and its parter BioNTech, whose shots have already been distributed to the U.S. and Britain. In its submission of data t...